The duty of the sponsor is to notify JAZMP regarding all substantial amendments in accordance with Article 23 of the Rules on clinical trials  of medicinal products.
The duty of the sponsor is to notify JAZMP regarding all substantial amendments in accordance with Article 23 of the Rules on clinical trials  of medicinal products.